You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 4, 2026

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Naoto Muraoka1,2, Bingyun Sun3,4, Charles E Murry1,2,5,6
1From the Institute for Stem Cell and Regenerative Medicine (N.M., C.E.M.), Department of Pathology, University of Washington, Seattle.
No abstract available in PubMed .